Carregant...

Proof of Principle for a Novel Class of Antihypertensives That Target the Oxidative Activation of PKG Iα (Protein Kinase G Iα)

Arterial hypertension continues to be a major health burden. Development of new antihypertensive drugs that engage vasodilatory mechanisms not harnessed by available therapies offer therapeutic potential. Oxidants induce an interprotein disulfide in PKG Iα (protein kinase G Iα) at C42, which is asso...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hypertension
Autors principals: Burgoyne, Joseph R., Prysyazhna, Oleksandra, Richards, Daniel A., Eaton, Philip
Format: Artigo
Idioma:Inglês
Publicat: Lippincott, Williams & Wilkins 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5548503/
https://ncbi.nlm.nih.gov/pubmed/28716990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09670
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!